BC Generations Project

Your time today builds a healthier tomorrow.

  • Contact Us
  • BC Generations Project
  • Home
  • About
    • The Project
      • Project team
      • Timeline
    • Study details
    • Our participants
  • Participants
    • Member news
    • Moving? Don’t Lose Touch
    • Consent
  • Researchers
    • Overview of access
    • Data Information
    • Biosample Information
    • Study Documents
    • Requesting access
    • Ancillary study
  • Impact
    • Approved studies
    • Publications
  • News
Home / Blog / New clinical study taps into Project cohort

New clinical study taps into Project cohort

October 18, 2016

Can early signs of cancer be detected through a simple blood test? The CANDACE study has been approved to recruit eligible participants from the BC Generations Project cohort to assess the usefulness of an experimental new technology.

For many types of cancer, early detection means more treatment options and better outcomes. Most population-based cancer screening methods (e.g. mammography or colonoscopy) only search for a single type of cancer. Other methods that could detect a number of different cancers during a single screening – such as MRI – are too costly and invasive for routine, widespread use.

CANDACE is a clinical study aimed at determining whether it is possible to detect early signs of cancer through a simple blood test. The study will assess the clinical utility of Pathway Genomics’ CancerInterceptTM Detect test. Based on a technology developed by Boreal Genomics, this experimental test uses blood samples to identify mutations in genes that are associated with the development and progression of cancer.

The CANDACE study has been approved to recruit eligible participants from the BC Generations Project cohort. Project participants who meet the study criteria will be contacted by the BC Generations Project and invited to participate. As always, participation is completely voluntary.

The study aims to recruit 1,000 healthy volunteer participants who have not been diagnosed with cancer in the past. Participants who have a positive test result will be examined further using standard-of-care diagnostic methods (e.g. medical imaging) to confirm whether the blood test has correctly indicated the presence of a cancer.

The CANDACE study is led by the BC Cancer Agency in collaboration with the University of British Columbia, Boreal Genomics, the BC Generations Project and Pathway Genomics. For a related study outside the BC area, see https://www.pathway.com/healthy1000/.

Filed Under: Blog, Featured, Member News

Primary Sidebar

Research icon

Research in action

Learn about research studies accessing the BC Generations Project's data and samples.

Living icon

A living laboratory

Our participants represent a broad cross section of BC adults. Learn more about the cohort.

Footer

BC Generations Project
Lower Mainland: 604-675-8221
Toll free: 1-877-675-8221
Email: bcgenerationsproject@bccrc.ca

  • Home
  • About
  • Participants
  • Researchers
  • Impact
  • News

Copyright © 2023 · BC Generations Project